WallStreetZenWallStreetZen

NASDAQ: MIRA
Mira Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MIRA stock forecasts and price targets.

Forecast return on equity

Is MIRA forecast to generate an efficient return?

Company
-101.84%
Industry
-46.9%
Market
329.83%
MIRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MIRA forecast to generate an efficient return on assets?

Company
-100.72%
Industry
18.22%
MIRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MIRA earnings per share forecast

What is MIRA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.19
Avg 2 year Forecast
-$0.18

MIRA revenue forecast

What is MIRA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0

MIRA vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
MIRA$1.49N/AN/A
MDCX$1.89$27.00+1,328.57%Strong Buy
SCLX$16.63N/AN/A
AMRN$14.36$12.00-16.43%Strong Sell
OGN$7.17$9.50+32.50%Strong Sell
View Top General Drug Manufacturer Stocks

Mira Pharmaceuticals Stock Forecast FAQ

What is MIRA's earnings growth forecast for 2025-2026?

(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 123.12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,953.18%.

Mira Pharmaceuticals's earnings in 2025 is -$48,710,479.On average, 3 Wall Street analysts forecast MIRA's earnings for 2025 to be -$49,974,922, with the lowest MIRA earnings forecast at -$48,015,121, and the highest MIRA earnings forecast at -$51,444,773.

In 2026, MIRA is forecast to generate -$7,688,450 in earnings, with the lowest earnings forecast at -$7,386,942 and the highest earnings forecast at -$7,914,580.

If you're new to stock investing, here's how to buy Mira Pharmaceuticals stock.

What is MIRA's revenue growth forecast for 2025-2026?

(NASDAQ: MIRA) Mira Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 2.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,453.97%.

Mira Pharmaceuticals's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast MIRA's revenue for 2025 to be $0, with the lowest MIRA revenue forecast at $0, and the highest MIRA revenue forecast at $0.

In 2026, MIRA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is MIRA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: MIRA) forecast ROA is -100.72%, which is lower than the forecast US Drug Manufacturers - General industry average of 18.22%.

What is MIRA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: MIRA) Mira Pharmaceuticals's current Earnings Per Share (EPS) is -$2.63. On average, analysts forecast that MIRA's EPS will be -$1.19 for 2025, with the lowest EPS forecast at -$1.15, and the highest EPS forecast at -$1.23. In 2026, MIRA's EPS is forecast to hit -$0.18 (min: -$0.18, max: -$0.19).

What is MIRA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: MIRA) forecast ROE is -101.84%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.